Android app Apple app link

Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid

By Yahoo! Finance   |   1 month ago
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid

Pfizer has filed a lawsuit against Metsera and Novo Nordisk, alleging breach of merger agreement obligations. Pfizer seeks to block Metsera from accepting Novo's $8.5 billion bid. The legal battle unfolds as Pfizer gains antitrust clearance for acquiring Metsera.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.